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Abstract
Herbal and traditional medicine is commonly and widely used in Palestine. There has been no ethno pharmacological study to document the usefulness of 
traditional or medicinal plants from Palestine against leishmaniasis, a spectrum of severe parasitic diseases that occur worldwide and is caused by protozoa of 
the genus Leishmania. The aim of the present study was to collect and analyze some of the traditionally used medicinal plants from Palestine against Leishmania 
major parasites that cause cutaneous leishmaniasis. 
Plant materials were collected during spring and summer of the year 2011, identified and the voucher numbers were kept at Al-Quds University Gardens 
(AQUG). The whole plant (except roots), flowers, fruits or seeds were collected, washed with distilled water, air dried in the shade for 20 days and then 
powdered in an electric grinder. For each plant species, alcoholic and dimethyl sulfoxide extracts were tested in vitro against L. major promastigotes and their 
antileishmanial activities were evaluated by Alamar Blue bioassay. 
Twenty plant species belonging to14 families were examined for their in vitro anti-parasitic effect against L. major. Among the total crude extracts tested; 
five were found to have various levels of activities (20%), some extracts having significant antileishmanial activity with IC50 values ranging from 8.83 to 100 
µg/mL. The most active crude extracts were from the shoots of Artemisia inculta and Malva sylvestris with activity of 84.1%, IC50 = 8.8 µg/mL. And 90.1%, 
IC50 = 19.5 µg/mL respectively. 
The results demonstrate that the crude extracts of Artemisia inculta and Malva sylvestris showed promising antileishmanial activity, further and extensive 
studies should be carried out; particularly bio-guided fractionation to identify the active fraction and further chemical characterization of structure
ABBREVIATIONSAQUG: Al-Quds University Gardens; DMSO: Dimethyl Sulfoxide; EtOH: Ethanol; FBS: Fetal Bovine Serum; PBS: Phosphate Buffered Saline; IC50: 50% Inhibitory Concentration
INTRODUCTIONThrough much of human history, plants have been used in medical treatments; such traditional medicine is still widely practiced today. Moreover, a huge number of novel drug components have been isolated from natural plant sources, where many of these plants and their extracts were used in traditional medicine [1,2]. This natural secretes, in the form of herbal remedies, could be explored based on information collected from local residents and traditional practitioners in different parts of the world [3-5]. Investigations carried out on folk medicinal plants with a potential of being curative have provided many clinical drugs for various infectious diseases. It has been reported that many plant-derived compounds 
regarded as important drugs currently in use, the majority of these compounds were derived from traditional medicines [6-9]. Leishmaniasis is a disease caused by different species of 
Leishmania parasites and is transmitted by the bite of a female 
phlebotomine sand fly. Depending on the parasite species, three different forms of the disease existed, ranging from the 
mild self-limiting cutaneous form, but causing disfigurement of the skin and lifelong scars, to more severe and life threatening mucucocutaneous and visceral forms. Leishmaniasis is a disease with a large worldwide distribution, endemic in 98 countries where about 1/3 of the cutaneous cases occur in the Americas, the Mediterranean basin and western Asia with 70-75% of the cases registered in Afghanistan, Algeria, Colombia, Brazil, Iran, Syria, Ethiopia, Costa Rica, Peru and northern Sudan [10]. Incidence of the disease is increasing worldwide due to the expansion of international travel, especially among countries that are at war and/or where there are no effective vaccines for humans [11,12]. Additional problems are the emergence of strains resistant to 
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first-line drugs as well as increasing cases of co-infection with HIV/AIDS [13-16].Chemotherapy of parasitic diseases including leishmaniasis 
is still challenging, the drug efficacy is mostly limited by the 
inability of the pharmaceuticals to reach its target in a sufficient 
concentration and for a sufficient duration. The available drugs currently in use for the treatment of leishmaniasis include the followings: pentavalent antimonials; N-methylglucamine and 
antimoniate are considered the first-line treatment and, as a second option, amphotericin B or pentamidine. However, these drugs are disadvantaged by emergence of resistant parasites, parenteral administration, lethal side effects, high price and low availability especially in low-income and developing countries. The absence of vaccines and other effective prophylactic measures indicates the need for new therapies against leishmaniasis to cure people in endemic areas. Natural products of plant origin are potential preparations have been used for centuries to treat empirically parasitic diseases including leishmaniasis for people around the world which stimulating clinical and laboratory research [17,18]. Palestine is distinguished for its availability of medicinal plants because of the unique geographical location and biodiversity; these plants have been used for a long period of time to treat various illnesses. The Palestinian mountains are rich in plant species; about 2953 species are found with more than 700 species being mentioned in published ethnobotanical data as medicinal herbs or as botanical pesticides [19-21]. In the present study, we investigated the in vitro antileishmanial activity of crude extracts from 20 medicinal plants from various regions in Palestine. These plants were used by the local people to treat many infectious diseases and have never evaluated for their activity against Leishmania parasites
MATERIALS AND METHODS 
Selection and collection of plant materialsThe list of medicinal plants in Palestine was reviewed with the aid of local traditional practitioners and botanists. Literature 
survey has been performed for specific reports on traditional, medical and therapeutic importance of Palestinian medicinal plants. Plant names were selected based on information available in the literature about their anti-leishmanial, anti-protozoal, anti-parasitic, antimicrobial or anti-oxidant activities, other plants were selected based on their uses in the Palestinian traditional medicine to treat bacterial, fungal or parasitic infections. Plant materials were collected during spring and summer of the year 
2011, identified by a botanist and the voucher numbers were kept at Al-Quds University Gardens (AQUG) and available upon request. Based on the traditional reports on the plant part used 
medicinally [17,22,23], the whole plant (except roots), flowers, fruits or seeds were collected, washed with distilled water, air dried in the shade for 20 days and then powdered in an electric grinder. The list of plant names used in this study can be found in Table (1).
Preparation of the crude extractsAqueous and organic extractions were done for each plant; each powdered plant material was extracted by maceration of 
plant powder in absolute ethanol and dimethyl sulfoxide (DMSO) separately for 72 hours at room temperature with gentle shaking. The quantity of solvent used for each extraction was 10 times 
the quantity of plant material. The filtrate obtained through 
Whatman No. 1 filter paper was concentrated under reduced pressure in a rotary evaporator at 30 ºC. The extraction yields were calculated and the plant crude materials were dissolved in their respective solvents to a concentration of 160 mg/mL. All crudes were kept at room temperature and protected from light until further processing. 
Preparation of Leishmania major promastigotesPromastigotes of L. major (1 × 106 parasites/well) were cultured in micro plates with 96 wells (Corning) containing Schneider’s medium with 10% heat inactivated fetal bovine 
serum (FBS), 100 IU/mL. Penicillin and 100 μg/mL. streptomycin. Promastigotes were then washed 3 times with phosphate-buffered saline (PBS) by centrifugation at 1500 rpm for 10 min at room temperature. 
In vitro test for anti-leishmanial activityThe in vitro test was performed using Alamar Blue bioassay [24] and it includes the following: cultured promastigotes at the log phase (1 × 106 parasites/mL.) were seeded in 125 µl 
Schneider’s medium in 96-well flat-bottom micro-plate, and 
then, 1 μl of each crude extract dissolved in DMSO and EtOH were 
mixed separately in 124 μl culture medium and transferred into 
the well. The final concentration of EtOH and DMSO was less than 0.1% (v/v) as this concentration will not affect the parasite growth rate, mobility and morphology. Amphotericin B (0.5 μg/mL.) was used as drug positive control while parasites only in culture media were used as growth control. Negative control was cultured in media only. Each crude extract was tested in triplicate. The micro plate was incubated at 26°C in 5% CO2 for 24 h in which 10% Alamar Blue (Sigma) was added to each well and the plates were incubated at 26°C for another 24 h. Optical density values (test wavelength 450 nm; reference wavelength 630 nm) were measured using a micro plate reader. The decrease 
of fluorescence (which indicated inhibition) was expressed as the 
percentage of the fluorescence of the control cultures. 
Determination of the 50% effective concentration 
(IC50)The IC50 values at the 95% confidence interval were calculated using sigmoid dose-response curves (Graph Pad Prism version 5.01 software Inc., San Diego, CA)
Phytochemical analysisThe crude extracts that have anti-leishmanial activity were screened for the presence of different phytochemicals; alkaloids, 
anthocyanins and betacyanin, quinones, flavonoids, phenols, saponins, tannins, sterols, triterpenoids, terpenoids and acids, following the standard methods of analysis [25-27]
RESULTSTwenty plant species belonging to14 families were examined for their in vitro antiparasitic effect against L. major using the Alamar Blue bioassay method. Local names in Palestine, their 
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Table 1: Selected plant species used in this study with scientific and popular names, plant parts used and their medical importance.
No Plant scientific name English name Parts used
AQUG  
voucher 
number
Medical importance
Antimicrobial 
activities 
Reference1 Artemisia inculta Delile White Wormwood Shoots PS-Ai10 Anti-Helicobactor pylori [40]2 Coridothymus capitatus (L.) Rchb.f. Capitate Thyme Leaves PS-Cc19 Antioxidant [41]3 Sinapis arvensis L. Mustard/wild Shoots PS-Sa11 Antibacterial [19]4 Arum palaestinum Boiss Arum Leaves PS-Ap20 Anticancer [42]5 Malva sylvestris L. Common Mallow Leaves PS-Ms50 Antileishmanial,  Antibacterial, Anti-
inflammatory
[43]6 Carum carvi L. Caraway Seeds PS-Cc12 Treatment of Gastrointestinal disorders, 
increase flow of breast milk
[44]7 Trigonella berythea Boiss. & Blanche Fenugreek Seeds PS-Tb21 Anti-diabetic activity [45]8 Carthamus tinctorius L. Safflower Flowers PS-Ct33 Treatment of dysmenorrhea, amenorrhea, postpartum abdominal pain. [46]9 Paronychia argentea Lam. Silvery Whitlow Flowers PS-Pa15 Aphrodisiac, Diuretic [47]
10 Dittrichia viscosa (L) Greuter Inula Leaves PS-Dv22 Antidiabetic, antiphlogistic, antiviral, antifungal, antibacterial, and antiseptic properties [48]11 Crataegus aronia (L) Bosc ex DC Hawthorn, Azarole Leaves PS-Ca55 Antioxidant, treatment of cardiovascular diseases [49]12 Punica granatum L. Pomegrante Peel PS-Pg70 Anticancer, anti-inflammatory, treatment of Osteoarthritis, traditional remedies against diarrhea, dysentery and intestinal parasites. [50]Seeds Antidiarrhoeal activity, antparasitic, antioxidant [4]13 Rosmarinus officinalis L. Rosemary Shoots PS-Ro80 Anti-inflammatory, antitumor, antioxidant,  antimicrobial, Antileishmanial, and Antitrypanosomal [51]14 Nigella ciliaris DC. Black cumin Seeds PS-Nc30 Anticancer, anti-oxidant [21]15 Hibiscus sabdariffa L. Roselle Flowers PS-Hs17 Treatment of Melanoma [52]16 Ficus carica L. Fig tree Leaves PS-Fc40 Antimicrobial, antifungal, antioxidant, antiviral, 
anti-inflammatory
[53]White sap17 Citrullus colocynthis (L) Schrader Colocynth Leaves PS-Cc18 Antidiabetic [54]Fruits antimicrobial [55]18 Origanum majorana L. Sweet-Marjoram Leaves PS-Om60 Antimicrobial, antioxidant [56]19 Calotropis procera (Aiton) Dryand. Apple of Sodom Leaves PS-Cp22 Anti-inflammatory [57]20 Pimpinella anisum L. Anis Seeds PS-Pa02 Antiviral, antioxidant, muscle relaxant, analgesic and anticonvulsant activity,  hypoglycemic and hypolipidemic effect [58]
Abbreviations: AQUG: Al-Quds University Gardens; PS: Palestine
scientific names and medicinal and traditional uses are listed in Table (1). Antileishmanial activities and IC50 results are listed in 
Table (2). Among the total crude extracts tested; five were found to have various levels of activities (20%), some extracts having 
significant antileishmanial activity with IC50 values ranging from 8.83 to 100 µg/mL. Extracts with IC50 less than 100 µg/mL, were considered active. One prominent extract, Artemisia inculta of the ASTERACEAE (COMPOSITAE) family, was the most potent (activity 84.1% and IC50 = 8.8 ± 2.3µg/mL). This was considered as promising activity, as shown in Table (2). Others have moderate to very little activities with IC50 values between 19.5 - 100 µg/mL., these include extracts of Malva sylvestris of MALVACEAE family 
with leishmanicidal activity of 90.1% and IC50 of 19.5 ± 16.3 µg/mL (Table 2). On the other hand, three plant extracts including 
Trigonella berythea, Carthamus tinctorius, and Paronychia 
argentea showed very low or even negligible activities with IC50 values between 37.01 – 77.84 µg/mL. Three plant extracts, 
Sinapis arvensis, Crataegus aronia, and Calotropis procera may be considered inactive with IC50> 100 µg/mL. Twelve plant extracts including Coridothymus capitatus, Arum palaestinum, 
Carum carvi , Dittrichia viscose, Punica granatum, Rosmarinus 
officinalis, Nigella ciliaris, Hibiscus sabdariffa, Ficus carica, 
Citrullus colocynthis, Origanum majorana, and Pimpinella anisum were found inactive. 
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Table 2: In vitro antileishmanial activity and cytotoxicity of the plant extracts used in this study.
No. Plant Scientific name Family name
AQUG 
voucher 
number
Solvent (a) Parts used
Antileishmanial activity
(b) Activity 
(%)
IC50, µg/ml
Average ± 
Standard 
Deviation1 Artemisia inculta Delile ASTERACEAE (COMPOSITAE) PS-Ai10 DMSO Shoots 84.1 8.83± 2.32 Coridothymus capitatus (L.) Rchb.f. LAMIACEAE (LABIATAE) PS-Cc19 Leaves3 Sinapis arvensis L. BRASSICACEAE (CRUCIFERAE) PS-Sa11 Ethanol Shoots 20 >1004 Arum palaestinum Boiss ARACEAE PS-Ap20 Leaves5 Malva sylvestris L. MALVACEAE PS-Ms50 DMSO Leaves 90.1 19.50±16.36 Carum carvi L. APIACEAE (UMBELLIFERAE) PS-Cc12 Seeds7 Trigonella berythea Boiss. & Blanche FABACEAE (LEGUMINOSAE) PS-Tb21 Ethanol Seeds 30 77.84± 46.28 Carthamus tinctorius L. ASTERACEAE (COMPOSITAE) PS-Ct33 DMSO Flowers 82.1 37.01± 0.0019 Paronychia argentea Lam CARYOPHYLLACEAE PS-Pa15 DMSO Shoots 74.5 77.80± 46.310 Dittrichia viscosa (L.) Greuter ASTERACEAE (COMPOSITAE) PS-Dv22 Leaves11 Crataegus aronia (L.) Bosc ex DC ROSACEAE PS-Ca55 DMSO Leaves 31.9 >10012 Punica granatum L. PUNICACEAE PS-Pg70 PeelFruits13 Rosmarinus officinalis L. LAMIACEAE (LABIATAE) PS-Ro80 Shoots14 Nigella ciliaris DC. RANUNCULACEAE PS-Nc30 Seeds15 Hibiscus sabdariffa L. MALVACEAE PS-Hs17 Leaves16 Ficus carica L. MORACEAE PS-Fc40 LeavesWhite sap17 Citrullus colocynthis (L.) Schrader CUCURBITACEAE PS-Cc18 LeavesFruits18 Origanum majorana L. LAMIACEAE (LABIATAE) PS-Om60 Leaves19 Calotropis procera (Aiton) Dryand. APOCYNACEAE PS-Cp22 Ethanol Leaves 3 >10020 Pimpinella anisum L. APIACEAE (UMBELLIFERAE) PS-Pa02 Seeds
Abbreviations: AQUG: Al-Quds University Gardens; PS: Palestine; DMSO: Dimethyl Sulfoxide
Among the active extracts, four were extracted with DMSO and only one with ethanol. Therefore, DMSO extracts were generally more active than the ethanol ones. The results of the qualitative 
phytochemical analysis of the five active extracts showed that anthocyanins and betacyanins are found in only one extract, 
Paronychia argentea, which also contains phenols, saponins, tannins, and acids. Flavonoids were found only in the most active extract, Artemisia inculata, which also contain phenols, saponins, and triterpenoids. Trigonella berythea contains saponins, tannins, terpenoids, and acids. Carthamus tinctorius which has moderate activity contains saponins, tannins, terpenoids, and acids. Although none of the studied extracts contained alkaloids, quinones, or sterols, each of the studied plant extract contained at least two classes of secondary metabolites. The detailed phytochemical composition is shown in Table (3). The presence of these phytoconstituents is thought to be responsible for antileichmanial activity
DISCUSSIONMedicinal plants have been known throughout history as most appropriate sources of active chemicals and their derivatives to be used as templates for designing and developing 
more effective compounds, preferably with fewer side effects. Most plants that have medicinal properties in Palestine have not yet been thoroughly evaluated for their biological activities. 
In vitro screenings of various medicinal plants currently used 
in traditional medicine are essential and important first steps 
to prove the efficacy and safety of these plants in the treatment of infectious diseases, especially leishmaniasis, in poor and developing countries. This study is designed to obtain preliminary results on the antileishmanial effects of selected medicinal plants from Palestine on L. major. Our results strongly suggest that Artemisia 
inculta and Malva sylvestris could be promising for treatment of leishmaniasis demanding a search for new chemotherapeutic agents. However, further studies need to be carried out, in order to isolate, purify and characterize active ingredients in pure forms and to understand the mechanisms of action and to evaluate the highly active crudes for further drug development. Toxicity against human cells should be done once active materials have 
been purified. The cytotoxicity was not carried out at this level 
for two reasons; firstly the plants that showed activity against 
Leishmania promastigotes are edible and traditionally used as medicinal plants for the treatment of various illnesses, and 
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Table 3: Phytochemical composition of the five active plant extracts.
Plant sample Phytochemical composition
Alka-
loids
Anthocy-
anines & 
Betacyanin
Qui-
nones
Flavo-
noids
Phe-
nols
Sapon-
ins
Tan-
nins Sterols
Triterpe-
noids
Terpe-
noids Acids
Artemisia inculta Delile + + + +
Malva sylvestris L
Trigonella berythea-Boiss. & Blanche + + +
Carthamus tinctorius L + + +
Paronychia argentea Lam + + + + +secondly, the extracts are solely in crude and not in pure form and the active ingredient that confers toxicity for Leishmania is mixed up with many others that may have toxicity against human cells; therefore, cytotoxicity tests at this level may lead to exclusion of active crude extracts that may have toxic ingredients. The most active extracts come from the use of DMSO as extraction solvent, suggesting that the less polar compounds are responsible for the observed activity. Plants found active were also extracted with dichloromethane with almost the same activity, however dichloromethane is recommended since it has a boiling temperature much less than DMSO and hence easily evaporated and removed. Natural products are potential sources of new and selective agents for the treatment of important tropical diseases caused by protozoans and other parasites [28-30]. The most active extract, Artemisia inculta, contains polyphenolic compounds like 
flavonoids and triterpenoids (Table 3) which are believed to have the ability to inhibit trypanosomal and leishmanial infections 
without significant toxicity to mammalian cells [31-33]. Different 
Artemisia species have been reported to have in vitro and in vivo activity against various Leishmania species; Artemisia annua leaves extract was proved to have leishmanicidal activity against 
L. donovani which causes visceral leishmaniasis [34,35]. The second promising plant is Malva sylvestris, reported in this study 
to have antileishmanial activity for the first time; it is an edible plant and people in Palestine used it extensively.The activity of these plants is believed to be structure- 
dependent, according to literature flavonoids bind to C-terminal nucleotide-binding domain (NBD2) of the P- glycoprotein-like transporter in L. tropica which is involved in parasite multidrug resistance [36,37]. Flavonoids also inhibit important enzymes 
or proteins; ﬂavonoids quercetin inhibits DNA topoisomerases, 
promoting site specific DNA cleavage resulting in the growth inhibition of L. donovani promastigotes and amastigotes [38]. 
In other parasites, flavonoids inhibit the synthesis of heat shock proteins (Hsp90, Hsp70, and Hsp27); these factors are important to protect virulent parasites from the effects of host immune responses [39]. Based on susceptibility tests using Alamar Blue Bioassay, phytochemicals are routinely evaluated for antileishmanial 
activity. For crude extracts, activity is considered to be significant if IC50 values are below 20 μg/mL. and moderate when 20 < IC50< 
100 μg/mL. Therefore, the activity recorded with Artemisia 
inculta, Malva sylvestris, Coridothymus capitatus, Trigonella 
berythea, Carthamus tinctorius, and Paronychia argentea against L. major can be considered important. Previous reports documented leishmanicidal activity of Artemisia species from Iran against L. major promastigotes [35]. The genus Artemisia 
L. (Astraceae) is a large, heterogeneous and widely distributed throughout the world. These species are perennial, biennial and annual herbs or small shrubs.There was no toxicity mentioned in the literature or concerns about the use of these medicinal plants. The samples were not assayed on intracellular amastigote forms, which should be done the next step of evaluation and validation of these plants. Further analysis still to be done on the active crudes; bio-guided fractionation should also be conducted and may lead to the isolation of the major components in the active crude.
CONCLUSIONOur study investigated twenty selected crude plant extracts and their antileishmanial activity. Among them, Artemisia inculta and Malva sylvestris exhibited promising results that may lead to the development of effective and affordable antileishmanial drugs. In developing countries, these results provide an alternative way to use plant-based remedies that might be safer, cheaper, and less toxic than existing prescription medicines. This 
is an area rich in possibilities, and the world’s flora represents an enormous source of material for testing. However, further studies are needed, particularly bio-guided fractionation to identify the active faction and further chemical characterization of structure. This research belongs to the global effort carried by researchers around the world to locate compounds with antileishmanial activity by validating natural products as genuine sources for drug discovery
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